Patupilone (Epothilone B) for Recurrent Glioblastoma: Clinical Outcome and Translational Analysis of a Single-Institution Phase I/II Trial

Publisher： Karger

E-ISSN： 1423-0232|83|1|1-9

ISSN： 0030-2414

Source： Oncology, Vol.83, Iss.1, 2012-06, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenges in clinical trial design for recurrent glioblastoma

By McNeill Katharine A   Fine Howard A  

Clinical Investigation, Vol. 3, Iss. 9, 2013-09 ,pp. : 835-848

Future Science

Access to resources Recommend Favorite

Image‐guided video assisted thoracoscopic surgery (iVATS) ‐ phase I‐II clinical trial

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 1, 2015-07 ,pp. : 18-25

John Wiley & Sons Inc

Access to resources Recommend Favorite

Seborrhoeic keratosis removal in a multicentre phase I/II clinical trial using a novel topical formulation (BL‐5010)

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 247-249

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sequential Local Injection of Low-Dose Interferon-Beta for Maintenance Therapy in Stage II and III Melanoma: A Single-Institution Matched Case-Control Study

By  

Oncology, Vol. 82, Iss. 3, 2012-03 ,pp. : 139-146

Karger

Access to resources Recommend Favorite

Effects of Patupilone (Epothilone B; EPO906), a Novel Chemotherapeutic Agent, in Hepatocellular Carcinoma: An in vitro Study

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 292-296

Karger

Access to resources Recommend Favorite